Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00244101 · ClinicalTrials.gov registry record · Phase 3
Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome
A Phase 3 study, sponsored by Vermont Oxford Network.
- Completed
- Registry status
- Phase 3
- Development phase
- 648
- Enrollment target
NCT00244101 is a Phase 3 study that has completed, run by Vermont Oxford Network. The registered enrollment target is 648 participants.
The verdict
NCT00244101, a Phase 3 study, has completed, sponsored by Vermont Oxford Network.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 648 participants
- Enrollment target
Study Summary
The best mode of delivery room stabilization for premature infants at high risk for respiratory distress syndrome is unknown. The protocol evaluates the impact of three distinct methods of post-delivery stabilization and subsequent early respiratory care on chronic lung disease and survival in premature infants at high risk for respiratory distress syndrome.
Interventions
- DRUG PS Group
- DEVICE NCPAP Group
- DRUG ISX Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 648 participants |
| Start Date | 2003-08 |
| Est. Completion | 2011-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00244101
The ClinicalTrials.gov registry entry for NCT00244101 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 648 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vermont Oxford Network, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PS Group is the first listed.
NCT00244101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00244101 about?
NCT00244101 is a clinical study titled "Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome". The best mode of delivery room stabilization for premature infants at high risk for respiratory distress syndrome is unknown. The protocol evaluates the impact of three distinct methods of post-delivery stabilization and subsequent early respiratory care on chronic lung disease and survival in prema...
What is the current status of trial NCT00244101?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 648 participants. The study started on 2003-08. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00244101?
The interventions under investigation include: PS Group (DRUG), NCPAP Group (DEVICE), ISX Group (DRUG).
Who is sponsoring clinical trial NCT00244101?
This trial is sponsored by Vermont Oxford Network, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.